Pay to Marwadi

Company Profile

KRISHNA INSTITUTE OF MEDICAL SCIENCES LTD

NSE : KIMSBSE : 543308ISIN CODE : INE967H01017Industry : Hospital & Healthcare ServicesHouse : Private
BSE1988.301.25 (+0.06 % )
PREV CLOSE (Rs.) 1987.05
OPEN PRICE (Rs.) 2029.45
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 2067
TODAY'S LOW / HIGH (Rs.)1984.45 2029.45
52 WK LOW / HIGH (Rs.)1452.6 2357
NSE1991.95 7.95 (+0.4 % )
PREV CLOSE(Rs.) 1984.00
OPEN PRICE (Rs.) 2000.10
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 1991.95 (1572 )
VOLUME 20363
TODAY'S LOW / HIGH(Rs.) 1985.00 2018.45
52 WK LOW / HIGH (Rs.)1457.05 2356.4

Company Profile

Smart Quotes

1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Trade Value (Rs. in Lacs) 0.00
Dividend Yield(%) 0.00
TTM EPS (Rs.) 32.72
P/E Ratio 60.77
Book Value (Rs.) 227.22
Face Value (Rs.) 10
MCap (Rs. in Mn) 159119.25
Price/Earning (TTM) 51.21
Price/Sales (TTM) 13.14
Price/Book (MRQ) 8.75
PAT Margin (%) 22.30
ROCE (%) 22.58
Incorporation Year : 1973

Management Info :

Bhaskara Rao Bollineni - Chairman Bhaskara Rao Bollineni - Managing Director

Registered Office :

Address : D. No.1-8-31/1,Minister's Road, ,
Secunderabad,
Telangana-500003

Phone : 040-44186000 / 44850000 / 44885184

Registrar's Details : Link Intime India Pvt Ltd.
Coimbatore Branch Surya , 35 Mayflower Avenue,Behind Senthil Nagar,Sowripalayam Road,Coimbatore
Listing : BSE, NSE
NEWS More
02May05-02-2024$Krishna Institute of Medical Sciences informs about board meeting Krishna Institute of Medical

Pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Krishna Institute of Medical Sciences has informed that a meeting of the Board of Directors of the company is scheduled to be held on Thursday, May 16, 2024 to consider and approve the audited (Standalone & Consolidated) financial results of the company for the quarter and financial year ended March 31, 2024. Further, in accordance with the Company’s Code of Conduct for the Prevention of Insider Trading, the Company has intimated its ‘designated persons’ regarding the closure of the Trading Window for trading in the Company’s equity shares from Monday i.e., April 01 2024 till the expiry of 48 hours from the date the said financial results are made public.

The above information is a part of company’s filings submitted to BSE.

Pursuant to Regulation 29(1) of SEBI (Listing Obligations and D..
27Apr04-27-2024$Krishna Institute of Medical Sciences informs about credit rating Krishna Institute of Medical
Pursuant to Regulation 30 read with Part A of Schedule III to the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, as amended and SEBI Circular dated July 13, 2023, Krishna Institute of Medical Sciences has informed that CRISIL Ratings has upgraded the rating of Krishna Institute of Medical Sciences ('The Company') as enclosed.

The above information is a part of company’s filings submitted to BSE.

Pursuant to Regulation 30 read with Part A of Schedule III to t..
25Jan01-25-2024$Krishna Institute of Medical Sciences informs about completion of tenure of independent director Krishna Institute of Medical
In terms of provisions of Regulation 30 read with Schedule III of the Listing Regulations, Krishna Institute of Medical Sciences has informed that Rajeswara Rao Gandu (DIN: 05339318) has completed his 2nd term of 5 years as an Independent Director of the Company and ceases to be Independent Director with effect from the end of the day 24th January 2024 @11.59.59 pm. The details as required under Listing Regulations read with SEBI Circular No. CIR/CFD/ CMD/4/2015 dated 9th September 2015, are in ‘Annexure A’ attached to this letter. The above information will also be available on the Company's website: www.kimshospitals.com. 

The above information is a part of company’s filings submitted to BSE.

In terms of provisions of Regulation 30 read with Schedule III..
23Jan01-23-2024$Krishna Institute of Medical Sciences informs about board meeting Krishna Institute of Medical
Krishna Institute of Medical Sciences has informed that the meeting of the Board of Directors of the Company is scheduled on 03/02/2024 to consider and approve the un-audited (Standalone & Consolidated) financial results of the company for the quarter and nine months ended December 31, 2023.

The above information is a part of company’s filings submitted to BSE.

Krishna Institute of Medical Sciences has informed that the mee..
10Jan01-10-2024$Krishna Institute of Medical acquires additional stake in Sarvejana Healthcare Krishna Institute of Medical

Krishna Institute of Medical Sciences has made a further investment by acquiring an additional equity stake of 5.04% in M/s Sarvejana Healthcare, material subsidiary Company. Consequently, the Company now holds 64.14% of the total paid-up Equity Share capital of M/s Sarvejana Healthcare. The company being the Holding Company of Sarvejana Healthcare has made further investment in its material subsidiary as a strategic investment.

Krishna Institute of Medical Sciences offers a comprehensive range of healthcare services including oncology, cardiac sciences, neurosciences, gastric sciences, orthopaedics, renal sciences, organ transplantation, and mother & child care.


Krishna Institute of Medical Sciences has made a further invest..
Financials More
Rs. in Millions
QTR Dec 23 ANNUAL 23
Net Profit583.552524.89
Gross Profit 777.07 3373.33
Operating Profit 917.063837.8
Net Sales 3020.6311320.23
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group More
RainbowChildrenS Med (BSE)
 1461.55 (5.43%)
M.Cap ( in Cr)
14834.98
Apollo Hospital Ent. (BSE)
 6009.00 (0.89%)
M.Cap ( in Cr)
86400.20
Jupiter Life Line (BSE)
 1223.15 (1.41%)
M.Cap ( in Cr)
8019.71
HealthcareGlobal (BSE)
 369.50 (4.26%)
M.Cap ( in Cr)
5146.75
Fortis Healthcare (BSE)
 451.70 (2.52%)
M.Cap ( in Cr)
34101.46
Shareholding Pattern More
FI/BANKS/INSURANCE 5.61 %
PROMOTERS 38.82 %
MUTUAL FUNDS/UTI 26.33 %
NON-INSTITUTION 11.32 %
GOVERNMENT 0 %
FII 0 %
MF HOLDINGS More
F & O Quotes